| Patricia A Heinz, CNM | |
|
4705 Montgomery Blvd Ne, Suite 301, Albuquerque, NM 87109-1226 | |
| (505) 727-4500 | |
| (505) 727-4505 |
| Full Name | Patricia A Heinz |
|---|---|
| Gender | Female |
| Speciality | Certified Nurse Midwife (cnm) |
| Experience | 28 Years |
| Location | 4705 Montgomery Blvd Ne, Albuquerque, New Mexico |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1093741985 | NPI | - | NPPES |
| 14978385 | Medicaid | NM |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Southwest Medical Associates, Llc | 7214831114 | 291 |
News Archive
Physicians at the Heart Hospital became the first team in the UK to treat a patient with an experimental new therapy designed to repair damage to cardiac muscle resulting from a heart attack. If successful, this treatment would give doctors the ability to improve the hearts of people with heart failure, rather than just treating the symptoms.
Schering-Plough Corporation has announced that Schering-Plough K.K., the company's subsidiary in Japan, has submitted a New Drug Application (J-NDA) to the Ministry of Health, Labor and Welfare (MHLW) seeking marketing approval for PEG-INTRON(R) (peginterferon alfa-2b) Powder for Injection for use in combination with REBETOL(R) (ribavirin) Capsules for the treatment of chronic hepatitis C.
The drug pentoxifylline appears to have limited benefit in the first-line treatment of mouth ulcers due to recurrent apthous stomatitis, according to a report in the April issue of Archives of Dermatology.
Durata Therapeutics today announced the Company has attained worldwide rights for the development and commercialization of Durata's lead product, dalbavancin, a long-acting, intravenous (IV) lipoglycopeptide for the treatment of acute bacterial skin and skin structure infections (abSSSI). In December 2010, Durata acquired from RaQualia Pharma commercialization rights for dalbavancin in Japan.
› Verified 3 days ago
| Entity Name | Southwest Medical Associates, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1164491072 PECOS PAC ID: 7214831114 Enrollment ID: O20031121000724 |
News Archive
Physicians at the Heart Hospital became the first team in the UK to treat a patient with an experimental new therapy designed to repair damage to cardiac muscle resulting from a heart attack. If successful, this treatment would give doctors the ability to improve the hearts of people with heart failure, rather than just treating the symptoms.
Schering-Plough Corporation has announced that Schering-Plough K.K., the company's subsidiary in Japan, has submitted a New Drug Application (J-NDA) to the Ministry of Health, Labor and Welfare (MHLW) seeking marketing approval for PEG-INTRON(R) (peginterferon alfa-2b) Powder for Injection for use in combination with REBETOL(R) (ribavirin) Capsules for the treatment of chronic hepatitis C.
The drug pentoxifylline appears to have limited benefit in the first-line treatment of mouth ulcers due to recurrent apthous stomatitis, according to a report in the April issue of Archives of Dermatology.
Durata Therapeutics today announced the Company has attained worldwide rights for the development and commercialization of Durata's lead product, dalbavancin, a long-acting, intravenous (IV) lipoglycopeptide for the treatment of acute bacterial skin and skin structure infections (abSSSI). In December 2010, Durata acquired from RaQualia Pharma commercialization rights for dalbavancin in Japan.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Patricia A Heinz, CNM 4705 Montgomery Blvd Ne, Suite 301, Albuquerque, NM 87109-1226 Ph: (505) 727-4500 | Patricia A Heinz, CNM 4705 Montgomery Blvd Ne, Suite 301, Albuquerque, NM 87109-1226 Ph: (505) 727-4500 |
News Archive
Physicians at the Heart Hospital became the first team in the UK to treat a patient with an experimental new therapy designed to repair damage to cardiac muscle resulting from a heart attack. If successful, this treatment would give doctors the ability to improve the hearts of people with heart failure, rather than just treating the symptoms.
Schering-Plough Corporation has announced that Schering-Plough K.K., the company's subsidiary in Japan, has submitted a New Drug Application (J-NDA) to the Ministry of Health, Labor and Welfare (MHLW) seeking marketing approval for PEG-INTRON(R) (peginterferon alfa-2b) Powder for Injection for use in combination with REBETOL(R) (ribavirin) Capsules for the treatment of chronic hepatitis C.
The drug pentoxifylline appears to have limited benefit in the first-line treatment of mouth ulcers due to recurrent apthous stomatitis, according to a report in the April issue of Archives of Dermatology.
Durata Therapeutics today announced the Company has attained worldwide rights for the development and commercialization of Durata's lead product, dalbavancin, a long-acting, intravenous (IV) lipoglycopeptide for the treatment of acute bacterial skin and skin structure infections (abSSSI). In December 2010, Durata acquired from RaQualia Pharma commercialization rights for dalbavancin in Japan.
› Verified 3 days ago
Alisha R Smith, CNM Advanced Practice Midwife Medicare: Medicare Enrolled Practice Location: 4640 Jefferson Ln Ne, Albuquerque, NM 87109 Phone: 505-843-6168 | |
Melissa Kolkena, CNM, WHNP-BC Advanced Practice Midwife Medicare: Medicare Enrolled Practice Location: 4705 Montgomery Blvd Ne Ste 301, Albuquerque, NM 87109 Phone: 505-727-7800 | |
Laura Migliaccio, Advanced Practice Midwife Medicare: Medicare Enrolled Practice Location: 2211 Lomas Blvd Ne, 4th Floor Ambulatory Care Ctr, Albuquerque, NM 87106 Phone: 505-272-2242 Fax: 505-272-1109 | |
Wendy Kimmelman, CNM Advanced Practice Midwife Medicare: Medicare Enrolled Practice Location: 201 Cedar St Se Ste 5600, Albuquerque, NM 87106 Phone: 505-563-6000 Fax: 505-727-9590 | |
Dr. Kim J Cox, CNM, PHD Advanced Practice Midwife Medicare: Not Enrolled in Medicare Practice Location: 2502 Marble Ave Ne, Msc 09 5350, 1 University Of New Mexico, Albuquerque, NM 87131 Phone: 505-272-0850 Fax: 505-272-8901 | |
Ms. Robyn Lawton, CNM Advanced Practice Midwife Medicare: Medicare Enrolled Practice Location: 2211 Lomas Blvd. Ne, 4th Floor Ambulatory Care Ctr, Albuquerque, NM 87106 Phone: 505-272-2245 Fax: 505-272-1109 | |
Deborah Radcliffe, CNM Advanced Practice Midwife Medicare: Not Enrolled in Medicare Practice Location: 4th Ambulatory Care Ctr, 2211 Lomas Blvd. Ne, Albuquerque, NM 87131 Phone: 505-272-2245 |